Stopping Oral Antiviral Therapy in Chronic Hep B Possible for Some People Stopping Oral Antiviral Therapy in Chronic Hep B Possible for Some People

A new analysis provides insight into what happens after stopping tenofovir disoproxil fumarate (TDF) in chronic hepatitis B patients with persistent viral suppression who took the drug for at least eight years.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news